The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

The GOLD 2017 strategy document recommends that the pharmacological management of COPD patients be based on the risk of future exacerbations and the severity of symptoms. A threshold of two moderate exacerbations or one hospitalization is used to define high-risk patients. The FORWARD study was a ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Vezzoli, Stefano, Petruzzelli, Stefano, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680966/
https://www.ncbi.nlm.nih.gov/pubmed/29138555
http://dx.doi.org/10.2147/COPD.S141416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680966/
https://www.ncbi.nlm.nih.gov/pubmed/29138555
http://dx.doi.org/10.2147/COPD.S141416

Ejemplares similares